Generic Times Product News

Pharmacy Times
Volume 0

AmlodipineBesylate Tablets

Marketed by:Teva PharmaceuticalsUSA (North Wales, Pa)

Compared to:Norvasc Tablets(Pfizer Inc)

Indication:July 10, 2007?Teva Pharmaceuticals announcedthe introduction and availability of AmlodipineBesylate Tablets. These tablets are indicated for thetreatment of hypertension (used alone or in combinationwith other antihypertensive agents); chronicstable angina (used alone or in combination withother antianginal drugs); and confirmed or suspectedvasospastic angina (Prinzmetal?s or variant angina;used as monotherapy or in combination withother antianginal drugs). These tablets are availablein 2.5-, 5-, and 10-mg strengths in bottles of 90tablets and in 5-mg strength in bottles of 300tablets.

Dosage Form:Tablets: 2.5, 5, and 10 mg

For More Information:www.tevausa.com888-TEVA USA (888-838-2872)

Atenolol Tablets USP

Marketed by:Caraco PharmaceuticalLaboratories Ltd (Detroit, Mich)

Compared to:Tenormin (AstraZenecaPharmaceuticals LP)

Indication:July 11, 2007?CaracoPharmaceutical Laboratoriesannounced that the FDA grantedfinal approval for its abbreviated new drug applicationfor Atenolol Tablets USP. Atenolol Tablets areindicated in the management of hypertension, thelong-term management of patients with anginapectoris, and the management of hemodynamicallystable patients with definite or suspected acutemyocardial infarction to reduce cardiovascular mortality.These tablets are available in 3 strengths: 25,50, and 100 mg.

Dosage Form:Tablets: 25, 50, and 100 mg

For More

Loratadine OrallyDisintegratingTablets

Marketed by:Ohm Laboratories Inc(Princeton, NJ), a whollyowned subsidiary ofRanbaxy LaboratoriesLtd (RLL)

Compared to:Claritin Reditabs (Schering-Plough HealthcareProducts)

Indication:April 12, 2007?Ohm Laboratories announced thatRLL received FDA approval to manufacture andmarket its Loratadine Orally Disintegrating Tablets,10 mg. This long-acting antihistamine agent is indicatedfor the temporary relief of runny nose; sneezing;itching of the nose or throat; and itchy, wateryeyes due to hay fever or other respiratory allergiesin adults and children aged 6 years and older.

Dosage Form:Tablets: 10 mg

For More

Metoprolol SuccinateExtended-release Tablets

Marketed by:KV Pharmaceutical Co(St. Louis, Mo)

Compared to:Toprol-XL (AstraZenecaPharmaceuticals LP)

Indication:July 26, 2007?KV PharmaceuticalCo announced the launch of its100- and 200-mg strengths of metoprolol succinateextended-release tablets. These tablets are indicatedfor the treatment of hypertension (used alone orin combination with other antihypertensive agents);the long-term management of angina pectoris; andthe treatment of stable, symptomatic (NYHA Class IIor III) heart failure of ischemic, hypertensive, or cardiomyopathicorigin.

Dosage Form:Tablets: 100 and 200 mg

For More

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.